Rheumatology

Menopause status significantly shapes the clinical presentation of systemic sclerosis (SSc), according to new findings from a multicenter analysis of over 1,500 women enrolled in the SPRING-SIR registry.

A new comparative analysis of international guidelines for psoriatic arthritis (PsA) management reveals key divergences in treatment strategies across leading rheumatology societies, underscoring ongoing challenges in global consensus despite shared therapeutic goals.

In a new multicenter study, researchers found that the effectiveness of a computerized patient decision aid (PtDA) for systemic lupus erythematosus (SLE) hinges not on where or how it is used but on whether patients view it fully and without interruptions.

Muscle impairments are a significant yet understudied burden in patients with osteogenesis imperfecta (OI), with consequences that extend far beyond bone fragility.

Lupus nephritis recurrence after kidney transplant may occur silently and more frequently than previously recognized, according to a new multisite retrospective study using both surveillance and indication biopsies.

Screening for latent tuberculosis (TB), hepatitis C virus (HCV), and occult hepatitis B virus (HBV) is critical before initiating biologic or targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARDs) in patients with rheumatoid arthritis (RA), according to a recent clinical audit conducted in Pakistan.

A new study suggests that mixed rhinitis (MR) may be a significantly underrecognized condition in children and adolescents previously diagnosed with allergic rhinitis (AR), with nearly half of patients potentially misclassified.

Stem cell–based therapies may offer a transformative approach for systemic sclerosis, according to a new review that evaluates both current limitations and emerging solutions in regenerative treatment.